WestmanEC, VernonMC. Has carbohydrate-restriction been forgotten as a treatment for diabetes mellitus? A perspective on the accord study design. Nutr Metab (Lond), 2008; 5: 10.
2.
FeinmanRD, PogozelskiWK, AstrupA, et al.Dietary carbohydrate restriction as the first approach in diabetes management: Critical review and evidence base. Nutrition, 2015; 31: 1–13.
3.
GriauzdeDH, Standafer LopezK, SaslowLR, RichardsonCR. A pragmatic approach to translating low- and very low-carbohydrate diets into clinical practice for patients with obesity and type 2 diabetes. Front Nutr, 2021; 8: 682137.
4.
GoldenbergJZ, JohnstonBC. Low and very low carbohydrate diets for diabetes remission. BMJ, 2021; 373: n262.
5.
SnorgaardO, PoulsenGM, AndersenHK, AstrupA. Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Res Care, 2017; 5: e000354.
6.
SainsburyE, KizirianNV, PartridgeSR, GillT, ColagiuriS, GibsonAA. Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract, 2018; 139: 239–252.
7.
DuBroffR, de LorgerilM. Fat or fiction: The diet-heart hypothesis. BMJ Evid Based Med, 2021; 26: 3–7.
8.
IbsenDB, JakobsenMU, HalkjaerJ, et al.Replacing red meat with other nonmeat food sources of protein is associated with a reduced risk of type 2 diabetes in a danish cohort of middle-aged adults. J Nutr, 2021; 151: 1241–1248.
9.
ChiavaroliL, LeeD, AhmedA, et al.Effect of low glycaemic index or load dietary patterns on glycaemic control and cardiometabolic risk factors in diabetes: Systematic review and meta-analysis of randomised controlled trials. BMJ, 2021; 374: n1651.
10.
ReynoldsAN, AkermanAP, MannJ. Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses. PLoS Med, 2020; 17: e1003053.
11.
ToshSM, ChuY. Systematic review of the effect of processing of whole-grain oat cereals on glycaemic response. Br J Nutr, 2015; 114: 1256–1262.
12.
MiaoM, HamakerBR. Food matrix effects for modulating starch bioavailability. Annu Rev Food Sci Technol, 2021; 12: 169–191.
13.
StephenAM, CummingsJH. Mechanism of action of dietary fibre in the human colon. Nature, 1980; 284(5753): 283–284.
14.
XuB, FuJ, QiaoY, et al.Higher intake of microbiota-accessible carbohydrates and improved cardiometabolic risk factors: A meta-analysis and umbrella review of dietary management in patients with type 2 diabetes. Am J Clin Nutr, 2021; 113: 1515–1530.
15.
SchwingshacklL, HoffmannG, LampousiAM, et al.Food groups and risk of type 2 diabetes mellitus: A systematic review and meta-analysis of prospective studies. Eur J Epidemiol, 2017; 32: 363–375.
16.
PanA, SunQ, BernsteinAM, MansonJE, WillettWC, HuFB. Changes in red meat consumption and subsequent risk of type 2 diabetes mellitus: Three cohorts of us men and women. JAMA Intern Med, 2013; 173: 1328–1335.
17.
U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015 – 2020 dietary guidelines for americans. https://health.gov/our-work/food-nutrition/previous-dietary-guidelines/2015. Published 2015. Accessed August2021.
18.
MontagneseC, SantarpiaL, BuonifacioM, et al.European food-based dietary guidelines: A comparison and update. Nutrition, 2015; 31: 908–915.
19.
WolkA.Potential health hazards of eating red meat. J Intern Med, 2017; 281: 106–122.
20.
ZhongVW, Van HornL, GreenlandP, et al.Associations of processed meat, unprocessed red meat, poultry, or fish intake with incident cardiovascular disease and all-cause mortality. JAMA Intern Med, 2020; 180: 503–512.
21.
MichaR, WallaceSK, MozaffarianD. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: A systematic review and meta-analysis. Circulation, 2010; 121: 2271–2283.
22.
TobiasDK, WittenbecherC, HuFB. Grading nutrition evidence: Where to go from here?. Am J Clin Nutr, 2021; 113: 1385–1387.
23.
JohnstonBC, ZeraatkarD, HanMA, et al.Unprocessed red meat and processed meat consumption: Dietary guideline recommendations from the nutritional recommendations (nutrirecs) consortium. Ann Intern Med, 2019; 171: 756–764.
24.
PollakovaD, AndreadiA, PacificiF, Della-MorteD, LauroD, TubiliC. The impact of vegan diet in the prevention and treatment of type 2 diabetes: A systematic review. Nutrients, 2021; 13: 2123.
25.
WurtzAML, JakobsenMU, BertoiaML, et al.Replacing the consumption of red meat with other major dietary protein sources and risk of type 2 diabetes mellitus: A prospective cohort study. Am J Clin Nutr, 2021; 113: 612–621.
26.
RajpathakSN, CrandallJP, Wylie-RosettJ, KabatGC, RohanTE, HuFB. The role of iron in type 2 diabetes in humans. Biochim Biophys Acta, 2009; 1790: 671–681.
27.
TongM, NeusnerA, LongatoL, LawtonM, WandsJR, de la MonteSM. Nitrosamine exposure causes insulin resistance diseases: Relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and alzheimer's disease. J Alzheimers Dis, 2009; 17: 827–844.
28.
BollaAM, CarettoA, LaurenziA, ScaviniM, PiemontiL. Low-carb and ketogenic diets in type 1 and type 2 diabetes. Nutrients, 2019; 11: 962.
29.
SchmidtS, ChristensenMB, SerifovskiN, et al.Low versus high carbohydrate diet in type 1 diabetes: A 12-week randomized open-label crossover study. Diabetes Obes Metab, 2019; 21: 1680–1688.
30.
Rabasa-LhoretR, GaronJ, LangelierH, PoissonD, ChiassonJL. Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen. Diabetes Care, 1999; 22: 667–673.
31.
HartM, PurseyK, SmartC. Low carbohydrate diets in eating disorders and type 1 diabetes. Clin Child Psychol Psychiatry, 2021; 26: 643–655.
32.
Mayer-DavisEJ, LaffelLM, BuseJB. Management of type 1 diabetes with a very low-carbohydrate diet: A word of caution. Pediatrics, 2018; 142: e20181536B.
33.
DimosthenopoulosC, LiatisS, KourpasE, et al.The beneficial short-term effects of a high-protein/low-carbohydrate diet on glycaemic control assessed by continuous glucose monitoring in patients with type 1 diabetes. Diabetes Obes Metab, 2021; 23: 1765–1774.
34.
RanjanA, SchmidtS, Damm-FrydenbergC, HolstJJ, MadsbadS, NorgaardK. Short-term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open-label crossover trial. Diabetes Obes Metab, 2017; 19: 1479–1484.
35.
McGaughSM, ZaharievaDP, PooniR, et al.Carbohydrate requirements for prolonged, fasted exercise with and without basal rate reductions in adults with type 1 diabetes on continuous subcutaneous insulin infusion. Diabetes Care, 2021; 44: 610–613.
36.
Goulet-GelinasL, SaadeMB, SuppereC, et al.Comparison of two carbohydrate intake strategies to improve glucose control during exercise in adolescents and adults with type 1 diabetes. Nutr Metab Cardiovasc Dis. 2021; 31: 1238–1246.
37.
McCarthyO, DeereR, ChurmR, et al.Extent and prevalence of post-exercise and nocturnal hypoglycemia following peri-exercise bolus insulin adjustments in individuals with type 1 diabetes. Nutr Metab Cardiovasc Dis. 2021; 31: 227–236.
38.
ColbergSR, SigalRJ, YardleyJE, et al.Physical activity/exercise and diabetes: A position statement of the american diabetes association. Diabetes Care, 2016; 39: 2065–2079.
39.
BrazeauAS, Rabasa-LhoretR, StrycharI, MircescuH. Barriers to physical activity among patients with type 1 diabetes. Diabetes Care, 2008; 31: 2108–2109.
40.
LivnyR, SaidW, ShiloS, et al.Identifying sources of support and barriers to physical activity in pediatric type 1 diabetes. Pediatr Diabetes, 2020; 21: 128–134.
41.
AdolfssonP, RiddellMC, TaplinCE, et al.Ispad clinical practice consensus guidelines 2018: Exercise in children and adolescents with diabetes. Pediatr Diabetes, 2018; 19 Suppl 27: 205–226.
42.
McCarthyMM, FunkM, GreyM. Cardiovascular health in adults with type 1 diabetes. Prev Med, 2016; 91: 138–143.
43.
RiddellMC, GallenIW, SmartCE, et al.Exercise management in type 1 diabetes: A consensus statement. Lancet Diabetes Endocrinol, 2017; 5: 377–390.
44.
CastleJR, El YoussefJ, WilsonLM, et al.Randomized outpatient trial of single- and dual-hormone closed-loop systems that adapt to exercise using wearable sensors. Diabetes Care, 2018; 41: 1471–1477.
45.
TalebN, EmamiA, SuppereC, et al.Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: Randomised controlled crossover trial. Diabetologia, 2016; 59: 2561–2571.
46.
HaidarA, LegaultL, MessierV, MitreTM, LerouxC, Rabasa-LhoretR. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: An open-label randomised controlled crossover trial. Lancet Diabetes Endocrinol, 2015; 3: 17–26.
47.
ZaharievaD, McGaughS, PooniR, VienneauT, LyT, RiddellM. Improved open-loop glucose control with basal insulin reduction 90 minutes before aerobic exercise in patients with type 1 diabetes on continuous subcutaneous insulin infusion. Diabetes Care, 2019; 42: 824–831.
48.
RickelsMR, DuBoseSN, ToschiE, et al.Mini-dose glucagon as a novel approach to prevent exercise-induced hypoglycemia in type 1 diabetes. Diabetes Car. 2018; 41: 1909–1916.
49.
SteineckIIK, RanjanA, SchmidtS, ClausenTR, HolstJJ, NørgaardK. Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: A randomised crossover study. Diabetologia, 2019; 62: 582–592.
50.
ZaharievaDP, McGaughS, PooniR, VienneauT, LyT, RiddellMC. Improved open-loop glucose control with basal insulin reduction 90 minutes before aerobic exercise in patients with type 1 diabetes on continuous subcutaneous insulin infusion. Diabetes Care, 2019; 42: 824–831.
51.
ZaharievaDP, MesserL, PaldusB, O'NealDN, MaahsD, RiddellMC. Glucose control during physical activity and exercise using closed loop technology in type 1 diabetes. Can J Diabetes, 2020; 44: 740–749.
52.
OzaslanB, PatekSD, BretonMD. Impact of daily physical activity as measured by commonly available wearables on meal time glucose control in type 1 diabetes. Diabetes Technol Ther, 2020; 22: 742–748.
53.
Garcia-TiradoJ, BrownSA, LaichuthaiN, et al.Anticipation of historical exercise patterns by a novel artificial pancreas system reduces hypoglycemia during and after moderate-intensity physical activity in people with type 1 diabetes. Diabetes Technol Ther, 2021; 23: 277–285.
54.
ZaharievaDP, TurksoyK, McGaughSM, et al.Lag time remains with newer real-time continuous glucose monitoring technology during aerobic exercise in adults living with type 1 diabetes. Diabetes Technol Ther, 2019; 21: 313–321.
55.
LiA, RiddellMC, PotashnerD, BrownRE, AronsonR. Time lag and accuracy of continuous glucose monitoring during high intensity interval training in adults with type 1 diabetes. Diabetes Technol Ther, 2019; 21: 286–294.
56.
Da PratoG, PasquiniS, RinaldiE, et al. Accuracy of cgm systems during continuous and interval exercise in adults with type 1 diabetes. J Diabetes Sci Technol. 2021:19322968211023522. Online ahead of print.
57.
FokkertM, van DijkPR, EdensMA, et al.Performance of the eversense versus the free style libre flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus. BMJ Open Diabetes Res Care, 2020; 8: e001193.
58.
GuillotFH, JacobsPG, WilsonLM, et al.Accuracy of the dexcom g6 glucose sensor during aerobic, resistance, and interval exercise in adults with type 1 diabetes. Biosensors (Basel). 2020; 10: 138.
59.
TanenbaumML, ZaharievaDP, AddalaA, et al.“I was ready for it at the beginning”: Parent experiences with early introduction of continuous glucose monitoring following their child's type 1 diabetes diagnosis. Diabetic Med, 2021; 38: e14567.